<DOC>
	<DOC>NCT02871206</DOC>
	<brief_summary>This study is a randomized controlled trial (RCT) comparing adjuvanted influenza vaccine (AV) to unadjuvanted inactivated influenza vaccine (IIV). Children in Hutterite colonies in Alberta and Saskatchewan will receive AV or IIV. The goal of this study is to determine whether the AV vaccine, can provide increased community-wide protection.</brief_summary>
	<brief_title>Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Group A: Receive Intervention Healthy children aged 6 months to 72 months Anaphylactic reaction to a previous dose of influenza vaccine or to any of its components Known Immunoglobulin E (IgE)mediated hypersensitivity to eggs manifested as hives, swelling of the mouth and throat, difficulty in breathing, hypotension, or shock Guillain Barr√© syndrome within eight weeks of a previous influenza vaccine Use of aspirin or salicylate containing products within 30 days before enrollment Group B: Household members of children in Group A</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>72 Months</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>